Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Colman

Showing results (491-500 of 646) with videos related to

Pageof 65
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammationM Devani, M Vecchi, S Ferrero, et al.
The American Journal of Physiology|March 11, 1986
Effects of verapamil and diltiazem on human platelet functionV P Addonizio, C A Fisher, J F Strauss, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
Thrombosis and Haemostasis|December 8, 1998
Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate modelP L Harper, F B Taylor, R A DeLa Cadena, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1993
Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusionY T Wachtfogel, U Kucich, C E Hack, et al.
Biochemistry|February 2, 1982
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitorsM Schapira, C F Scott, A James, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogenIrma M Sainz, Irma Isordia-Salas, Ricardo G Espinola, et al.
Thrombosis Research|June 1, 1976
Intravascular coagulation in hyperlipidemiaA C Carvalho, R S Lees, R A Vaillancourt, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1982
Release of lysosomal hydrolases during simulated extracorporeal circulationV P Addonizio, J F Strauss, L F Chang, et al.
Blood|August 1, 1979
Thromboxane synthesis and platelet protein release during simulated extracorporeal circulationV P Addonizio, J B Smith, L R Guiod, et al.
Pageof 65

Showing results (491-500 of 646) with videos related to

Sort By:
Pageof 65
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammationM Devani, M Vecchi, S Ferrero, et al.
The American Journal of Physiology|March 11, 1986
Effects of verapamil and diltiazem on human platelet functionV P Addonizio, C A Fisher, J F Strauss, et al.
Biochemistry|February 28, 2002
A nonhydrolyzable reactive cAMP analogue, (S(p))-8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic S-(methyl)monophosphorothioate, irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase at micromolar concentrationsSu H Hung, K S Madhusoodanan, Robert L Boyd, et al.
Thrombosis and Haemostasis|December 8, 1998
Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate modelP L Harper, F B Taylor, R A DeLa Cadena, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1993
Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusionY T Wachtfogel, U Kucich, C E Hack, et al.
Biochemistry|February 2, 1982
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitorsM Schapira, C F Scott, A James, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2005
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogenIrma M Sainz, Irma Isordia-Salas, Ricardo G Espinola, et al.
Thrombosis Research|June 1, 1976
Intravascular coagulation in hyperlipidemiaA C Carvalho, R S Lees, R A Vaillancourt, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1982
Release of lysosomal hydrolases during simulated extracorporeal circulationV P Addonizio, J F Strauss, L F Chang, et al.
Blood|August 1, 1979
Thromboxane synthesis and platelet protein release during simulated extracorporeal circulationV P Addonizio, J B Smith, L R Guiod, et al.
Pageof 65